Related Experiment Video
Updated: Jan 29, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Visualization, Data Extraction, and Multiparametric Analysis of 3D Pancreatic and Colorectal Cancer Cell Lines for
Mikhail A Trofimov1,2, Ilya P Bulatov1, Velemir S Lavrinenko1
1JSC BIOCAD, Intracity Municipality the Settlement of Strelna, ul. Svyazi, d. 38, Str. 1, Pomeshch. 89, 198515 Saint Petersburg, Russia.
This study introduces a new method for analyzing 3D cancer models, improving drug development. The approach accurately assesses compound efficacy in diverse cancer cell morphologies, overcoming limitations of standard assays.
Area of Science:
- Oncology
- Biotechnology
- Drug Discovery
Background:
- Three-dimensional (3D) cancer models, including spheroids, are vital for high-throughput screening (HTS) in drug development.
- Analyzing 3D cultures with heterogeneous morphology is challenging due to a lack of standardized visualization and multiparameter analysis techniques.
- Existing methods struggle with diverse spheroid morphologies, hindering accurate drug efficacy assessment.
Purpose of the Study:
- To develop and validate a novel computational method for analyzing morphological data from 3D cancer spheroids.
- To enable accurate multiparameter analysis of compound efficacy in cancer cell lines with diverse morphologies.
- To overcome the limitations of standard proliferation assays in heterogeneous 3D cell cultures.
Main Methods:
- An optimized CellProfiler pipeline was used to extract morphological data from colorectal and pancreatic cancer spheroids.
- A Python algorithm incorporating principal component analysis (PCA) was developed to weight and combine morphological features into a single metric.
- The developed method was validated by comparing its results with a standard Alamar Blue proliferation assay.
Main Results:
- A strong correlation (r = 0.89, ρ = 0.91, p < 0.001) was observed between the novel morphological analysis metric and the Alamar Blue proliferation assay.
- The method successfully determined IC50 values for compounds in cell lines (LoVo, CFPAC-1) where standard assays failed due to heterogeneous morphology.
- The developed technique provides informative multiparameter analysis of compound efficacy without requiring tracer dyes.
Conclusions:
- The novel methodology enhances the analysis of 3D cancer models, particularly those with heterogeneous morphologies.
- This approach accelerates preclinical drug development by providing accurate compound efficacy data more efficiently.
- By eliminating the need for tracer dyes, the method offers a cost-effective alternative for drug screening and development.
More Related Videos
Related Concept Videos
Cell Lines
Analysis of Population Pharmacokinetic Data
Cancer Survival Analysis
Overview of Microsoft Excel as a Data Analysis Tool
Performing a Simple Data Analysis using MS-Excel Function
SUM: This function calculates the total sum of a range of values. It's the foundation for aggregating data, essential for determining overall trends and totals in datasets.
AVERAGE: It computes the mean value of a given set of numbers, providing a quick insight into the central...
Statistical Software for Data Analysis and Clinical Trials

